VYNE Therapeutics

$7.63
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.19 (+2.55%) As of 4:40 PM UTC today

Why Robinhood?

You can buy or sell VYNE and other stocks, options, and ETFs commission-free!

About VYNE

VYNE Therapeutics, Inc. engages in the manufacture of pharmaceutical products. It develops and commercialize solutions using its proprietary Molecule Stabilizing Technology. Its commercial products include AMZEEQ and ZILXI. The company is headquartered in Bridgewater, NJ. The listed name for VYNE is VYNE Therapeutics Inc. Common Stock.

CEO
David Domzalski
Employees
40
Headquarters
Bridgewater, New Jersey
Founded
—
Market Cap
437.85M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
2.76M
High Today
$7.80
Low Today
$7.47
Open Price
$7.56
Volume
536.97K
52 Week High
$17.96
52 Week Low
$4.00

VYNE Earnings

-$0.95
-$0.63
-$0.32
$0.00
Q2 FY19
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Estimated
— per share
Actual
Available Mar 4, Pre-Market
Preview Earnings Call

You May Also Like

VCNX
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure